BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24786779)

  • 1. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
    Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose combination lercanidipine/enalapril.
    Hair PI; Scott LJ; Perry CM
    Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA
    J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L; Bruno RM; Cartoni G; Stea F; Magagna A; Virdis A; Grassi D; Ferri C; Taddei S
    Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
    Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
    Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
    Seravalle G; Brambilla G; Pizzalla DP; Casati A; Riva M; Cuspidi C; Bombelli M; Mancia G; Grassi G
    J Am Soc Hypertens; 2016 Mar; 10(3):244-51. PubMed ID: 26831124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
    Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
    J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of antihypertensive drugs prescribed in Ethiopian healthcare practice: A pilot prospective, randomized, open label study.
    Mengesha HG; Welegerima AH; Hadgu A; Temesgen H; Otieno MG; Tsegay K; Fisseha T; Getachew S; Merha Z; Tewodros H; Dabessa J; Gebreegzabher B; Petrucka P
    PLoS One; 2018; 13(9):e0203166. PubMed ID: 30204768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Am Soc Hypertens; 2014 Jun; 8(6):422-8. PubMed ID: 24836352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ; van Ouwerkerk BM; van der Meulen J; Zwinderman AH
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
    Barrios V; Escobar C; Echarri R
    Vasc Health Risk Manag; 2008; 4(4):847-53. PubMed ID: 19066001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.